US Stock MarketDetailed Quotes

OPT Opthea

Watchlist
  • 3.430
  • +0.070+2.08%
Close Apr 24 16:00 ET
284.18MMarket Cap-1425P/E (TTM)

About Opthea Company

Opthea Ltd. is a clinical stage biopharmaceutical company, which engages in the development of biological therapeutics for the treatment of progressive retinal diseases. It focuses on treating neovascular age-related macular degeneration and diabetic macular edema, which causes visual impairment among elderly and diabetic patients. The company was founded on October 17, 1984, and is headquartered in South Yarra, Australia.

Company Profile

SymbolOPT
Company NameOpthea
Issue Price13.50
Founded1984
CEODr. Megan Baldwin
MarketNASDAQ
Securities TypeDR
ADS Ratio1.0 : 8.0
Fiscal Year Ends06-30
Address650 Chapel Street,Suite 0403,Level 4
CitySouth Yarra
ProvinceVictoria (VIC)
CountryAustralia
Zip Code3141
Phone61-3-9826-0399
Websitehttp://www.opthea.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Megan Baldwin
  • Director, Chief Executive Officer and Managing Director
  • 1.22M
  • Judith J. Robertson
  • Chief Commercial Officer
  • 502.06K
  • Timothy E. Morris
  • Chief Financial Officer
  • --
  • Mark O Neill
  • Vice President, Chemistry, Manufacturing and Controls
  • --
  • Karen Adams
  • Vice President, Finance and Company Secretary
  • 379.27K
  • Bruno Gagnon
  • Senior Vice President, Global Clinical Operations
  • --
  • Jeremy M. Levin, D.Phil.
  • Chairman of the Board
  • 933.29K
  • Dr. Ian Leitch
  • Director of Clinical Research
  • --
  • Anshul Thakral
  • Director
  • --
  • Dr. Julia A. Haller, M.D.
  • Director
  • 642.69K
  • Susan Orr
  • Independent Director
  • 137.59K
  • Lawrence B. Gozlan
  • Independent Director
  • 656.47K
  • Quinton Oswald
  • Independent Director
  • 137.59K
  • Daniel K. Spiegelman
  • Independent Director
  • 771.22K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg